SNX-111: To start two trials this quarter

Neurex Corp. (NXCO), Menlo Park, Calif. Product: SNX-111, selective blocker of neuronal calcium channels as a neuroprotective Indication: Head trauma, coronary artery bypass graft (CABG) surgery Stat...